WPRIM Management System> DCMS> Translational and Clinical Pharmacology> 2016> 24> 4

Volume: 24 Issue: 4

1. Screening study for genetic polymorphisms affecting pharmacokinetics of pioglitazone. Page:194—202
2. An imputation-based method to reduce bias in model parameter estimates due to non-random censoring in oncology trials. Page:189—193
3. Pharmacokinetic characteristics of cilostazol 200 mg controlled-release tablet compared with two cilostazol 100 mg immediate-release tablets (Pletal) after single oral dose in healthy Korean male volunteers. Page:183—188
4. Pharmacokinetics and safety profiles of tadalafil/tamsulosin HCl fixed-dose combination capsule under fasted and fed condition in healthy volunteers. Page:175—182
5. Effects of JOINS® on the pharmacokinetic profiles of aceclofenac in healthy Korean volunteers: an open-label, multiple-dose, one sequence, two-period study. Page:169—174
6. R-based reproduction of the estimation process hidden behind NONMEM® Part 2: First-order conditional estimation. Page:161—168
7. Absorption and Half-Life. Page:157—160
8. Pitfalls in the calculation of hemodialysis clearance and in the assessment of dialysis efficacy. Page:153—156

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.